Trials / Conditions / Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
3 registered clinical trials studyying Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphom NCT06834373 | Mayo Clinic | Phase 2 |
| Recruiting | Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma NCT05755087 | Lapo Alinari | Phase 1 |
| Active Not Recruiting | Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large NCT02443077 | National Cancer Institute (NCI) | Phase 3 |